aap Implantate AG: Public Share Buyback Offer

The Management Board of aap Implantate AG resolved on 15 June 2017 with the approval of the Supervisory Board of the same day to purchase up to 2.25 million no-par value bearer shares of the company by means of a voluntary public share buyback offer against a cash payment of EUR 1.52 per no-par value share for a maximum total purchase price (including incidental costs) of up to EUR 3.5 million. The shares offered for purchase correspond to a proportion of up to approximately 7.3% of the company’s current share capital. With the public share buyback offer the Management Board makes use of the authorization granted by the Annual General Meeting resolution of 13 June 2014 to acquire treasury shares. With this measure aap Implantate AG implements the announced partial distribution of proceeds from last year’s sale of the subsidiary aap Biomaterials GmbH to shareholders.

The shares which are acquired as a result of the public share buyback offer can be used for all purposes permitted by law. The Management Board intends to redeem the shares acquired by means of the public share buyback offer.

The acceptance period starts on Tuesday, 20 June 2017, 00.00 hours (CEST) and ends on Monday, 10 July 2017, 24.00 hours (CEST). The offer document will be published before the start of the acceptance period on the corporate website of the company (www.aap.de) in the section “Investors / Share Buyback” as well as in the Federal Gazette under www.bundesanzeiger.de.